POSEIDA THERAPEUTICS INC's ticker is PSTX and the CUSIP is 73730P108. A total of 57 filers reported holding POSEIDA THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $66,709 | +35.2% | 28,029 | 0.0% | 0.00% | – |
| Q2 2023 | $49,331 | -3.3% | 28,029 | +145.1% | 0.00% | – |
| Q1 2022 | $51,000 | -34.6% | 11,437 | 0.0% | 0.00% | – |
| Q4 2021 | $78,000 | -22.8% | 11,437 | -17.2% | 0.00% | – |
| Q3 2021 | $101,000 | -91.1% | 13,813 | -87.9% | 0.00% | -100.0% |
| Q2 2021 | $1,139,000 | +2.0% | 113,737 | -2.8% | 0.00% | 0.0% |
| Q1 2021 | $1,117,000 | -59.8% | 117,036 | -53.8% | 0.00% | -66.7% |
| Q4 2020 | $2,777,000 | +13.0% | 253,160 | -8.6% | 0.01% | +20.0% |
| Q3 2020 | $2,458,000 | – | 276,976 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aisling Capital Management LP | 1,043,267 | $2,692,000 | 1.92% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 380,606 | $982,000 | 0.30% |
| Pentwater Capital Management LP | 4,967,227 | $12,815,000 | 0.15% |
| Atom Investors LP | 55,827 | $144,000 | 0.06% |
| Corton Capital Inc. | 14,978 | $39,000 | 0.04% |
| Forefront Analytics, LLC | 23,370 | $61,000 | 0.03% |
| Delphia (USA) Inc. | 15,799 | $41,000 | 0.03% |
| Advisory Services Network, LLC | 259,571 | $670,000 | 0.02% |
| Laurion Capital Management LP | 545,700 | $1,408,000 | 0.02% |
| MCF Advisors LLC | 59,659 | $154,000 | 0.02% |